Next big wave of patent cliffs ahead; biopharmaceutical M&A expected to increase (NYSE:ABBV)
Olivier LeMoal With a significant number of blockbuster drugs at risk of losing market exclusivity in the next five years, ...
Olivier LeMoal With a significant number of blockbuster drugs at risk of losing market exclusivity in the next five years, ...
fitbit recently filed a patent application (pdf) for a force-sensitive display that would allow blood pressure readings on wearable devices. ...
While device patents don't guarantee anything, they can offer a glimpse into areas a company is exploring. Earlier this week, ...
sanjeri/E+ via Getty Images Update 20:15: Add Exelixis's comment. exélixis (NASDAQ:EXEL) had a mixed ruling in its Cabometyx vs. MSN ...